Canada· CA-DIN-02340550
PMS-QUINAPRIL
A quinapril product containing quinapril (quinapril hydrochloride), registered in Canada by PHARMASCIENCE INC. The same ATC class is registered in 10 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Quinapril is registered in 10 of 19 countries.
Countries holding a registration under ATC C09AA06 (quinapril), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Quinapril · ATC C09AA06
10 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Franceprice
- Italyprice
- Netherlands
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of quinapril costs, country by country.
Normalised to the WHO defined daily dose (15 mg), so markets compare like for like.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Quinapril · price per daily dose (15 mg)
USD · FX 28 Sept 2026
- ES Spain$0.14
- IT Italy$0.13
- FR France$0.10
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- QUINAPRIL (QUINAPRIL HYDROCHLORIDE)
- Manufacturer
- PHARMASCIENCE INC
- Country
- Canada (CA)
- ATC code
- C09AA06
- ATC class
- Quinapril
- Defined daily dose
- 15 mg, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
407 interactions on record for quinapril.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Quinapril · interactions on record
407 records
- 11 severe
- 190 moderate
- 17 minor
- 114 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium gluconateA12BA05severe
- Potassium chlorideB05XA01severe
75 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Quinapril in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAccupro 5mg tabletsWaymade Healthcare Plc
- United StatesQuinaprilCipla USA Inc.
- BelgiumAccupril 10 mgPfizer
- FinlandAccuproPfizer Oy
- SpainACUPREL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULAPfizer S.L.
- PolandAccupro 10Pfizer Europe MA EEIG
- ItalyQUINAPRIL EGEG S.P.A.
- FranceACUITEL 20 mg, comprimé enrobé sécablePFIZER HOLDING FRANCE
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Belgium · Quinapril Eg
- Spain · Lidaltrin, Quinapril Normon
- France · Acuitel, Quinapril Biogaran
- Italy · Quinapril Eg, Quinazil
- Netherlands · Quinapril Cf
- Poland · Acurenal, Pulsaren
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd190e3b-4020-4ca6-936e-6f42c1e5d1b9 GET /v1/drugs/cd190e3b-4020-4ca6-936e-6f42c1e5d1b9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02340550",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "C09AA06",
"schedule": [
"Prescription"
],
"drug_code": "82613",
"strengths": [
"5 MG"
],
"ahfs_class": null,
"substances": [
"QUINAPRIL (QUINAPRIL HYDROCHLORIDE)"
],
"product_categorization": null
}See everything about quinapril.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.